Kent Armeson to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Kent Armeson has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.291
-
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer. 2021 03 15; 127(6):894-904.
Score: 0.151
-
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
Score: 0.140